← ZIMMER BIOMET HOLDINGS, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | $305.9m | $1.8b | ($379.2m) | $1.1b | ($138.9m) | $401.6m | $231.4m | $1.0b | $903.8m | $705.1m | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $304.6m | $1.8b | ($379.3m) | $1.1b | ($137.4m) | $402.1m | $232.4m | $1.0b | $905.3m | $705.1m | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | — | $290.2m | $1.0b | $903.8m | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | $291.2m | $1.0b | $905.2m | $705.1m | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | ($58.8m) | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | — | ($58.8m) | — | $0 | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | ($1.3m) | ($400k) | ($100k) | ($100k) | $1.5m | $500k | — | — | — | — | |
| Depreciation, Depletion and Amortization | $1.0b | $1.1b | $1.0b | $1.0b | $1.0b | $1.1b | $926.4m | $951.7m | $996.3m | $1.1b | |
| Depreciation | $466.7m | $454.1m | $442.6m | $421.8m | $435.1m | $451.7m | $399.6m | $390.2m | $404.4m | $427.9m | |
| Amortization of Intangible Assets | $565.9m | $603.9m | $595.9m | $584.3m | $597.6m | $615.7m | $526.8m | $561.5m | $591.9m | $665.9m | |
| Deferred Income Tax Expense (Benefit) | ($153.2m) | ($1.8b) | $13.4m | ($538.7m) | $12.0m | ($149.7m) | ($64.4m) | ($96.3m) | ($47.7m) | ($87.2m) | |
| Share-based Payment Arrangement, Noncash Expense | $57.3m | $53.7m | $65.5m | $84.3m | $79.7m | $85.3m | $105.0m | $99.8m | $101.0m | $90.2m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | $6.3m | $8.3m | — | — | — | — | — | — | — | — | |
| Goodwill and Intangible Asset Impairment | — | $331.5m | $979.7m | $70.1m | $645.0m | $16.3m | $292.8m | — | $0 | — | |
| Goodwill, Impairment Loss | — | $304.7m | $975.9m | — | $612.0m | — | $289.8m | — | $0 | $0 | |
| Impairment of Intangible Assets, Finite-lived | $30.0m | — | — | — | — | — | — | — | — | — | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | $30.0m | $26.8m | — | — | — | — | — | — | — | — | |
| Gain (Loss) on Extinguishment of Debt | ($53.3m) | — | — | — | — | ($165.1m) | — | — | — | — | |
| Income Tax Expense (Benefit) | $95.0m | ($1.3b) | $108.2m | ($225.7m) | ($137.0m) | $16.3m | $112.3m | $42.2m | $131.4m | $125.7m | |
| Other Nonoperating Income (Expense) | ($71.3m) | ($18.3m) | ($15.6m) | ($4.8m) | $25.4m | $11.8m | ($128.0m) | ($9.3m) | ($31.1m) | $25.5m | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Inventories | ($76.4m) | $122.8m | $199.5m | $125.2m | $40.8m | ($18.8m) | $75.6m | $240.4m | ($49.9m) | ($98.2m) | |
| Foreign Currency Transaction Gain (Loss), before Tax | — | $45.5m | ($41.2m) | ($3.4m) | ($22.8m) | ($3.7m) | $5.3m | ($21.6m) | ($26.1m) | ($14.2m) | |
| Gain (Loss) on Investments | — | — | — | — | — | — | ($116.6m) | $2.5m | $0 | $14.7m | |
| Goodwill | $10.6b | $10.7b | $9.6b | $9.6b | $9.3b | $9.2b | $8.6b | $8.8b | $9.0b | $9.9b | |
| Inventory Write-down | $195.4m | $128.4m | $226.1m | $221.4m | $250.0m | $181.7m | $137.3m | $155.2m | $149.9m | $311.2m | |
| Investment Income, Interest | $2.9m | $2.2m | — | — | — | — | — | — | — | — | |
| Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax | $25.8m | $3.8m | — | — | — | — | — | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | $1.6b | $1.6b | $1.7b | $1.6b | $1.2b | $1.5b | ($71.5m) | $0 | $1.5b | $1.7b | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $184.7m | $156.0m | $162.7m | $207.1m | $117.5m | $172.0m | $187.9m | $291.1m | $203.8m | $224.5m | |
| Payments for (Proceeds from) Other Investing Activities | $3.0m | $13.8m | $31.5m | $19.7m | $22.2m | $23.3m | $65.4m | ($11.8m) | $36.9m | $4.6m | |
| Net Cash Provided by (Used in) Investing Activities | ($1.7b) | ($510.8m) | ($416.6m) | ($729.3m) | ($613.8m) | ($503.6m) | ($7.2m) | $0 | $0 | ($2.0b) | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Long-term Debt | $750.0m | — | — | — | — | — | — | — | — | — | |
| Repayments of Long-term Debt | $800.0m | $940.0m | $1.4b | — | — | — | — | — | — | — | |
| Payments for Repurchase of Common Stock | $415.5m | — | — | — | — | — | $126.4m | $692.2m | $868.0m | $487.0m | |
| Payments of Ordinary Dividends, Common Stock | $188.4m | $193.6m | $195.2m | $196.7m | $198.5m | $200.1m | $201.2m | $200.9m | $196.0m | $190.3m | |
| Proceeds from (Payments for) Other Financing Activities | — | — | ($4.0m) | ($10.2m) | ($8.3m) | ($6.3m) | ($4.5m) | ($6.1m) | ($22.4m) | ($17.7m) | |
| Net Cash Provided by (Used in) Financing Activities | ($743.2m) | ($1.2b) | ($1.3b) | ($779.9m) | ($421.8m) | ($1.3b) | ($68.1m) | $0 | $0 | $326.0m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ($22.7m) | $29.3m | $18.4m | $75.1m | $184.2m | ($323.6m) | ($102.8m) | $40.1m | $109.7m | $66.4m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Income Taxes Paid, Net | — | — | — | — | — | — | — | — | — | $376.9m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.